BridgeMD
New treatment option for Vegetarian Diet
Official title Effect of Vegetarien Diet on Protein Digestibility in Young and Elderly Volunteers
ClinicalTrials.gov ID: NCT07521189
What this study is testing
What is Postprandial test?
Postprandial test is an investigational medicine, being studied as a potential treatment for vegetarian diet.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Plant proteins are usually less digestible than animal proteins, but they may benefit gut health through effects on the microbiome. The long-term impact of diets rich in plant products on protein digestion and metabolism is still unknown, especially in older adults with higher protein needs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Normal weight or overweight (18 \< BMI \< 30 kg m-²)
- Male or female
- Aged 18-23 years (young groups) or 65-75 years (older groups)
- Following an omnivorous diet (regular consumption of meat products, with meat intake \> 3 times/week and \> 70% of protein intake from animal...
- In good general health (WHO = 0)
You likely can't join if
- Adults under legal protection or unable to give informed consent (e.g., under guardianship, trusteeship, or legal protection)
- Any known food allergy
- Positive serology for HBsAg, anti-HBc, HCV, or HIV
- Anemia: hemoglobin level \< 13 g/dL in men and \< 12 g/dL in women
- Pregnant women or those who may be pregnant (based on a positive urine pregnancy test at inclusion)
- Excessive alcohol consumption (\> 2 drinks/day). Harmful alcohol use will be assessed by the investigator at inclusion.
See the full eligibility criteria
- Normal weight or overweight (18 \< BMI \< 30 kg m-²)
- Male or female
- Aged 18-23 years (young groups) or 65-75 years (older groups)
- Following an omnivorous diet (regular consumption of meat products, with meat intake \> 3 times/week and \> 70% of protein intake from animal sources) or vegetarian diet (exclusion of meat and fish/seafood, with \> 70%...
- In good general health (WHO = 0)
- Affiliated with a social security system
- Free and informed consent, provided in writing after receiving the information required by the Public Health Code
- Adults under legal protection or unable to give informed consent (e.g., under guardianship, trusteeship, or legal protection)
- Any known food allergy
- Positive serology for HBsAg, anti-HBc, HCV, or HIV
- Anemia: hemoglobin level \< 13 g/dL in men and \< 12 g/dL in women
- Pregnant women or those who may be pregnant (based on a positive urine pregnancy test at inclusion)
- Excessive alcohol consumption (\> 2 drinks/day). Harmful alcohol use will be assessed by the investigator at inclusion.
- Hypertension, diabetes, gastrointestinal, liver or kidney diseases, or severe heart disease. These conditions will be assessed by the investigator based on standard clinical evaluation and participants' self-reports at...
- Hypertension: significant arterial hypertension according to the investigator, or systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg at inclusion.
- Diabetes: type 1 or type 2 diabetes, or fasting blood glucose \> 1.25 g/L.
- Gastrointestinal disease: clinically significant gastrointestinal disorders (bleeding, vomiting, constipation/diarrhea grade \> 1) as judged by the investigator, any inflammatory bowel disease, or acute gastroenteritis...
- Liver disease: any significant hepatic disorder according to the investigator, or ASAT/ALAT \> 2.5 times the upper normal limit.
- High-level athletes (\> 8 hours of training per week)
- Blood donation within 8 weeks prior to study start
- Absence of free, informed, written consent after receiving the information required by the Public Health Code
- Not affiliated with a social security system
The study team makes the final eligibility decision.
Where it's taking place
- Bobigny, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bobigny, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.